RPS6KB1 and neoplasm: Our studies suggested that Super-EBS targeted phospho-S6K1 in tumor cells from different lineages, in cancer cell populations that represent plasticity as evidenced by neuroendocrine differentiation and/or are resistant to conventional therapy.